Only a few weeks following the launch of the new OPTIMIZER™ IVs system the company notes great interest in the new CCM system. During the EUROPACE Congress in Athens, a considerable number of inquiries for introduction of the CCM technology and the new OPTIMIZER system were recorded and booked. In the months to come, market introduction activities and cooperation with international users will be implemented.
Recent Posts
- Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase
- Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure
- Impulse Dynamics Expands Executive Leadership Team
- Impulse Dynamics Surpasses 10,000 Patients Benefiting from CCM® Therapy for Heart Failure
- Impulse Dynamics Completes $136M Financing Round
Archives
- June 2025
- November 2022
- June 2022
- May 2022
- April 2022
- March 2022
- January 2022
- February 2021
- January 2021
- April 2020
- March 2020
- December 2019
- November 2019
- October 2019
- August 2019
- March 2019
- May 2018
- December 2017
- August 2017
- May 2017
- March 2017
- September 2016
- May 2016
- March 2016
- January 2016
- November 2015
- August 2015
- July 2015
- January 2015
- December 2014
Recent Comments